InspireMD

Stent System Technology for Preventing Embolization

Health Tech & Life Sciences
Active
Public Tel Aviv-Yafo, Israel Founded 2005
Last updated 2026-06-18
Total raised
$229.5M
Last: PIPE 2025-08
Stage
Public
Founded
2005
Headcount
112
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

InspireMD is a commercial-stage medical device company with proprietary and innovative stent designs with integrated embolic prevention systems (EPS) delivering neurovascular protection and stroke prevention. Proprietary MicroNet mesh addresses the primary shortcomings and harmful consequences of conventional Carotid stenting and surgery.

InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for sustained embolic protection, neurovascular protection and stroke prevention. InspireMD is focused on changing the carotid/neurovascular market through expanding its portfolio of solutions along with pursuing applications of its MicroNet technology in other indications such as peripheral artery procedures.

Funding history · 7 rounds · $229.5M total

2025-08
2014-11
2013-10
2013-01
2012-11
2010-08
Convertible Debt $1.6M

Q&A

What is InspireMD's primary focus?
InspireMD is a commercial-stage medical device company focused on proprietary and innovative stent designs with integrated embolic prevention systems (EPS) for neurovascular protection and stroke prevention.
When was InspireMD founded?
InspireMD was founded in April 2005.
What is the employee count for InspireMD?
InspireMD has 51-200 employees.
What is InspireMD's current market capitalization?
InspireMD's market capitalization is $75,420,371.
When did InspireMD go public?
InspireMD went public on the NYSE in April 2011 with an Initial Public Offering.
What was InspireMD's most recent funding round?
In August 2025, InspireMD completed a PIPE round, raising $58,000,000 from investors OrbiMed and Marshall Wace.
Which investors participated in InspireMD's May 2023 PIPE round?
In May 2023, InspireMD raised $113,600,000 in a PIPE round with participation from Marshall Wace.
Who is the CEO of InspireMD?
Marvin Slosman is the CEO of InspireMD.

Team · 3

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

vascularhospitalsmedical-devicessurgerycardiologypreventionstentdoctorshealthcare-providersclinicsneurovascularstroketreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteinspiremd.com
LinkedInlinkedin.com/company/2504112
Facebookfacebook.com/InspireMD-Inc-1495734044064407
YouTubeyoutube.com/user/InspireMD

Identifiers & details

Founded2005-4
Employees (exact)112
OfficesWinsen (Luhe)
Market cap$75.4M
Status reasonPublic on NYSE on Apr 2011;

Acquisitions & public offerings

TypeDateExchangeTickerAmount
Apr 2011NSPR
Jul 2016NSPR$14.6M
Nov 2017NSPR$750K
Feb 2021NSPR$18.0M

Radar intelligence

Patents

EPO19

Publications (Crossref)

Works1

Web history (Wayback)

Domaininspiremd.com

Certificate / subdomain footprint

Subdomains56